Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now

Indonesia Berita Berita

Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

NPR's Ailsa Chang talks with Eli Lilly CEO David Ricks about the company's move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NPRHealth /  🏆 144. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Baca lebih lajut »

Drug Giant Eli Lilly Dramatically Slashes Price of InsulinDrug Giant Eli Lilly Dramatically Slashes Price of InsulinA hard-fought campaign to reduce the exorbitant price of insulin seems to finally be yielding some results.
Baca lebih lajut »

'Brilliant PR Move': Advocates Skeptical as Eli Lilly Vows 70% Insulin Price Cut'Congress, not greedy corporations trying to redeem their tarnished reputations, should be leading the way on reforms that put patients ahead of pharmaceutical profits.'
Baca lebih lajut »

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Baca lebih lajut »

Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'The announcement comes after waves of criticism from Americans saying the drug, which is vital to many people with diabetes, should be more accessible.
Baca lebih lajut »



Render Time: 2025-03-09 19:30:49